| Michelle Coley, LAC | |
|
2126 N 1st St, Suite F, Jacksonville, AR 72076-2868 | |
| (501) 982-5000 | |
| (501) 982-5007 |
| Full Name | Michelle Coley |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 2126 N 1st St, Jacksonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235661919 | NPI | - | NPPES |
| 227316795 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | A2203014 (Arkansas) | Primary |
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Coley, LAC 1815 Pleasant Grove Road, Jonesboro, AR 72405-7870 Ph: (870) 933-6886 | Michelle Coley, LAC 2126 N 1st St, Suite F, Jacksonville, AR 72076-2868 Ph: (501) 982-5000 |
News Archive
An experimental vaccine prevents the SARS virus from replicating in laboratory mice, according to a new report in the April 1 issue of Nature. Scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, developed the vaccine. The vaccine was tested in a mouse model of SARS infection recently validated by other NIAID investigators.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
Previous research has tied mental health issues and developmental disorders to gut health. Now, a team of British scientists has shown that foods that broaden the profile of helpful bacteria in the gut, which are collectively known as probiotics, can help ease anxiety and depression.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
› Verified 5 days ago
Amanda Patrice Mills, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2126 N 1st St, Suite F, Jacksonville, AR 72076 Phone: 501-982-5000 Fax: 501-982-5007 | |
Mrs. Tanya Nashel Miller, ADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1090 Arnold Dr, Jacksonville, AR 72099 Phone: 501-987-7338 Fax: 501-987-8087 | |
J Dawson Williams, D.MIN., LPC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 112 Fair Oaks Dr, Jacksonville, AR 72076 Phone: 501-837-9723 Fax: 877-775-2230 | |
Rita Jean Masterson, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2126 N 1st St Ste F, Jacksonville, AR 72076 Phone: 501-982-5000 Fax: 501-982-5007 | |
Mrs. Rebecca Williams Jackson, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2126 N. 1st Street Suite F, Jacksonville, AR 72076 Phone: 501-982-5000 Fax: 501-982-5007 | |
Mrs. Joanna L. Berry, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1200 James Street, Jacksonville, AR 72076 Phone: 501-982-5000 Fax: 501-982-5007 | |
Sheryl Jackson, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2126 N 1st St, Suite F, Jacksonville, AR 72076 Phone: 501-982-5000 Fax: 501-982-5007 |